Basic Information
Basic information for TMEM161B-AS1-203-14aa
Peptide Name TMEM161B-AS1-203-14aa
Genome Position chr5:88436477-88436518[+]
Species Human
Peptide Sequence MPIQGRVFIVETLA
Peptide Length 14
Unique No (TMEM161B-AS1-202-14aa,TMEM161B-AS1-206-14aa,TMEM161B-AS1-210-14aa,TMEM161B-AS1-213-14aa,TMEM161B-AS1-217-14aa,TMEM161B-AS1-220-14aa-2,TMEM161B-AS1-224-14aa,TMEM161B-AS1-226-14aa-1,TMEM161B-AS1-242-14aa-1,TMEM161B-AS1-243-14aa,TMEM161B-AS1-259-14aa-2)
Grand Average of Hydropathicity 0.9643
Relative Molecular Mass 1808.14
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000501869;TMEM161B-AS1-203
Transcript Length 880
Coding Ability 0.4182
DNA Sequence Corresponding to Peptide ATGCCAATTCAAGGCAGGGTCTTTATTGTTGAAACTCTTGCG
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :